的核查意见 中国银河证券股份有限公司 关于国新健康保障服务集团股份有限公司使用募集资金置换自 有资金预先支付的募投项目人员费用 中国银河证券股份有限公司（以下简称"保荐人"）作为国新健康保障服务 集团股份有限公司（以下简称"国新健康""公司"）2022 年向特定对象发行股 票并在主板上市的保荐人，根据《证券发行上市保荐业务管理办法》《深圳证券 交易所股票上市规则》《深圳证券交易所上市公司自律监管指引第 1 号——主板 上市公司规范运作》《上市公司募集资金监管规则》等有关法规和规范性文件的 要求，对公司使用募集资金置换自有资金预先支付的募投项目人员费用的事项进 行了审慎核查，具体情况如下： 一、募集资金基本情况 中国证券监督管理委员会于 2023 年 8 月 23 日出具了《关于同意国新健康保 障服务集团股份有限公司向特定对象发行股票注册的批复》（证监许可〔2023〕 1899 号），同意公司向特定对象发行股票的注册申请。 公司本次向特定对象发行股票 80,413,268 股，发行价格为 9.88 元/股。根据 大信会计师事务所（特殊普通合伙）出具的《国新健康保障服务集团股份有限公 司向特定对象发行股票募集资金 ...

中国银河证券股份有限公司 关于国新健康保障服务集团股份有限公司对全资子公司增资 暨部分募投项目实施主体股权结构发生变化 的核查意见 中国银河证券股份有限公司（以下简称"保荐人"）作为国新健康保障服务 集团股份有限公司（以下简称"国新健康"或"公司"）2022 年向特定对象发行 股票并在主板上市的保荐人，根据《证券发行上市保荐业务管理办法》《深圳证 券交易所股票上市规则》《深圳证券交易所上市公司自律监管指引第 1 号——主 板上市公司规范运作》等有关法规和规范性文件的要求，对国新健康向全资子公 司增资暨部分募投项目实施主体股权结构发生变化的事项进行了核查，具体核查 情况如下： 一、增资情况概述 国新健康于 2025 年 10 月 29 日召开第十二届董事会第五次会议和第十二届 监事会第四次会议，审议通过了《关于对全资子公司国新益康增资暨部分募投项 目实施主体股权结构发生变化的议案》，同意公司向全资子公司国新益康进行增 资，增资金额为 5,940 万元。截至本核查意见出具日，国新健康已与公司全资子 公司国新健康保障服务有限公司（以下简称"国新有限"）、国新益康数据（北京） 有限公司（以下简称"国新益康"）签订《股 ...

国新健康保障服务集团股份有限公司 2025 年第三季度报告 证券代码：000503 证券简称：国新健康 公告编号：2025-63 国新健康保障服务集团股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重 大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第三季度财务会计报告是否经过审计 □是 ☑否 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 ☑否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 增减 | | 年同期增减 | | 营业收入（元） | 74,871,674.67 | 19.26% | 170,401,734.11 | ...

Meeting Overview - The company will hold its second extraordinary general meeting of shareholders in 2025 on October 30 at 15:00 [3] - The meeting will be conducted both in-person and via online voting [4] - The record date for shareholders to attend the meeting is October 23, 2025 [4] Voting Procedures - Proposals 1 to 3 require a two-thirds majority of the voting rights held by attending shareholders for approval, while other proposals require a simple majority [5] - Shareholders can participate in online voting through the Shenzhen Stock Exchange trading system or the internet voting system on October 30, 2025 [9][13] Agenda Items - The meeting will discuss several proposals, including amendments to the company's articles of association and rules for shareholder and board meetings [5] - A proposal for the re-election of independent directors will also be presented [5] Registration Details - Registration for the meeting will be open from October 24 to October 28, 2025 [8] - Shareholders must provide identification and proof of shareholding to register [6][7] Contact Information - For inquiries, shareholders can contact the company's securities and investment department at the provided address and phone number [8]

证券简称：国新健康 证券代码：000503 编号：2025-60 国新健康保障服务集团股份有限公司 关于召开 2025 年第二次临时股东大会的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 本次股东大会的议案 1 至议案 3 需经出席会议的股东所持表决权的三分之 二以上通过，其他议案需经出席会议的股东所持表决权的二分之一以上通过。 国新健康保障服务集团股份有限公司（以下简称"公司"）于 2025 年 10 月 14 日召开第十二届董事会第四次会议，审议通过了《关于召开公司 2025 年第 二次临时股东大会的议案》公司已于 2025 年 10 月 15 日在《中国证券报》《上 海证券报》《证券时报》及巨潮资讯网（网址：www.cninfo.com.cn）发布了《关 于召开 2025 年第二次临时股东大会的通知》（公告编号：2025-59）。为了保护 投资者的合法权益，方便公司股东行使股东大会表决权，现发布关于召开 2025 年第二次临时股东大会的提示性公告。具体内容公告如下： 一、召开会议的基本情况 （一）股东大会届次：2025 年第二次 ...

Core Viewpoint - Guoxin Health is actively collaborating with insurance brokerage firms, health management service providers, and medical service institutions to explore a data-driven full-chain service model for health insurance, covering product design, marketing, underwriting, claims, and risk control [2] Group 1: Collaboration and Innovation - The company has established deep cooperative relationships with several domestic insurance companies to promote the implementation of innovative health insurance service models [2] - Guoxin Health is involved in projects such as the operation of public data authorization in Hangzhou and the personal medical insurance data authorization query in Pingxiang, Jiangxi, to enhance data compliance and operational practices [2] Group 2: Data Integration and Development - Guoxin Health has jointly established a company with Hubei Data Group to operate health medical big data in Central China, aiming to integrate and utilize health medical data resources within Hubei Province [2] - The newly formed company serves as a pilot for public data authorization operations in the "Three Medical" fields, facilitating the development and utilization of health medical data resources [2]

Core Insights - Guoxin Health aims to enhance comprehensive reform efficiency and improve coordination between front, middle, and back offices to increase work efficiency [2] - The company plans to continue adjusting its business structure, ensuring stable development of its three medical businesses while accelerating growth in data innovation and health service sectors [2] - Guoxin Health is focused on cost reduction and efficiency improvement, striving to maintain revenue growth throughout the year and reduce operational losses [2]

Core Insights - The company focuses on comprehensive management services for medical insurance funds, medical quality and safety services, drug and medical device regulation, and innovative health services [1] Business Coverage - The company's operations have expanded to cover over 200 regions across 29 provinces (autonomous regions and municipalities) in China [1]

Core Insights - Guoxin Health is actively participating in pilot projects under the guidance of national medical insurance data authorities, specifically in Hangzhou [1] - The company is implementing a public data authorization operation mechanism to facilitate the practical application of commercial insurance underwriting and claims scenarios [1] - Currently, the commercial insurance data services provided by the company focus on scenario operation services and do not involve data asset-related matters [1]

Core Insights - Guo Xin Health (000503.SZ) is actively participating in pilot projects under the guidance of national medical insurance data authorities [1] - The company has implemented a public data authorization operation mechanism in Hangzhou to facilitate the practical application of commercial insurance underwriting and claims scenarios [1] - Currently, the commercial insurance data services provided by the company focus on scenario operation services and do not involve data asset-related matters [1]